Corvus Pharmaceuticals, Inc (CRVS) Stock Price

12.31 ▼ -1.345 (-9.85%)
Open: 13.255 Vol: 3.48M Day's range: 12.19 - 13.32 May 15, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
CRVS Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 12.32▼ 12.32▼ 12.39▼ 14.72▼ 15.23▼
MA10 12.33▼ 12.42▼ 12.83▼ 15.09▼ 14.86▼
MA20 12.33▼ 12.89▼ 13.95▼ 15.51▼ 15.31▼
MA50 12.38▼ 14.42▼ 14.89▼ 15.16▼ 9.85▲
MA100 12.74▼ 14.95▼ 15.17▼ 15.18▼ 7.37▲
MA200 13.75▼ 15.24▼ 15.49▼ 11.04▲ 4.45▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.005▲ 0.036▲ -0.155▼ -0.280▼ -0.590▼
RSI 46.619▼ 24.749▼ 18.160▼ 34.188▼ 47.081▼
STOCH 53.340     16.819▼ 6.460▼ 43.549     35.698    
WILL %R -52.830     -92.114▼ -96.523▼ -97.425▼ -98.721▼
CCI 59.259     -73.955     -85.300     -258.876▼ -108.408▼
Latest Filters Detected On CRVS
▼ GAP $CRVS Open Gap Down %2 Set Alert
▼ BREAK $CRVS Price Breaks 60 Days Low Set Alert
▼ BREAK $CRVS Price Breaks 30 Days Low Set Alert
▼ BREAK $CRVS Price Breaks 20 Days Low Set Alert
▼ BREAK $CRVS Price Breaks 10 Days Low Set Alert
Corvus Pharmaceuticals, Inc News
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
Saturday, May 16, 2026 05:38 AM
Soquelitinib clinical development for atopic dermatitis advancing with Phase 1 cohort 4 positive data and initiation of Phase 2 trial during the quarter New immunologic and biomarker data supporting ...
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
Thursday, May 14, 2026 04:27 AM
New immunologic and biomarker data supports the potential of ITK inhibition with soquelitinib to increase persistent Treg cells and influence ...
CVS Health (NYSE:CVS) Delivers Impressive Q1 CY2026
Wednesday, May 06, 2026 05:27 AM
Diversified healthcare company CVS Health (NYSE:CVS) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 6.2% year on year to $100.4 billion. Its non-GAAP profit of $2.
CRVS historical stock data
date open high low close volume
15/05/26 13.255 13.32 12.19 12.31 3,481,846
14/05/26 15.70 15.79 13.21 13.655 3,932,500
13/05/26 15.82 16.14 15.55 15.84 1,365,913
12/05/26 15.72 16.12 15.44 15.97 903,951
11/05/26 15.87 16.85 15.745 15.81 1,139,767
08/05/26 14.81 15.80 14.7501 15.55 970,587
07/05/26 15.465 15.505 14.55 14.59 1,336,323
06/05/26 15.97 16.20 15.43 15.45 1,003,175
05/05/26 16.24 16.305 15.33 15.70 758,618
04/05/26 15.31 16.34 15.30 16.02 1,087,677
Quote Details
52wk Low:3.38
52wk High:26.95
Vol:3.48M
Avg Vol(3m):23.8M
1Y Chng:+198.79%
1M Chng:-16.32%
Add to Watch List
More Information
Index US Composite
Market Cap. 1.05B